EA201791483A1 - Фармацевтическая композиция для лечения микоза - Google Patents

Фармацевтическая композиция для лечения микоза

Info

Publication number
EA201791483A1
EA201791483A1 EA201791483A EA201791483A EA201791483A1 EA 201791483 A1 EA201791483 A1 EA 201791483A1 EA 201791483 A EA201791483 A EA 201791483A EA 201791483 A EA201791483 A EA 201791483A EA 201791483 A1 EA201791483 A1 EA 201791483A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mycosis
treatment
pharmaceutical composition
combination
benzydamine
Prior art date
Application number
EA201791483A
Other languages
English (en)
Other versions
EA035748B1 (ru
Inventor
Клаудио Миланесе
Алессандра Капеццоне Де Йоаннон
Серена Тоньяни
Лука Донати
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Publication of EA201791483A1 publication Critical patent/EA201791483A1/ru
Publication of EA035748B1 publication Critical patent/EA035748B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Настоящее изобретение относится к фармацевтическому составу, содержащему комбинацию бензидамина и противогрибкового активного ингредиента, указанная комбинация имеет синергический эффект в лечении микоза.
EA201791483A 2015-01-13 2016-01-08 Фармацевтическая композиция для лечения микоза EA035748B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150904 2015-01-13
PCT/EP2016/050272 WO2016113194A1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis

Publications (2)

Publication Number Publication Date
EA201791483A1 true EA201791483A1 (ru) 2017-11-30
EA035748B1 EA035748B1 (ru) 2020-08-05

Family

ID=52396443

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791483A EA035748B1 (ru) 2015-01-13 2016-01-08 Фармацевтическая композиция для лечения микоза

Country Status (29)

Country Link
US (1) US9962372B2 (ru)
EP (1) EP3244889B1 (ru)
JP (1) JP6714597B2 (ru)
KR (1) KR102606081B1 (ru)
CN (1) CN107106690B (ru)
AR (1) AR103381A1 (ru)
AU (1) AU2016208200B2 (ru)
BR (1) BR112017014295B1 (ru)
CA (1) CA2970060C (ru)
CY (1) CY1122979T1 (ru)
DK (1) DK3244889T3 (ru)
EA (1) EA035748B1 (ru)
ES (1) ES2794824T3 (ru)
GE (1) GEP20196962B (ru)
HK (1) HK1246146A1 (ru)
HR (1) HRP20200815T1 (ru)
HU (1) HUE049877T2 (ru)
IL (1) IL252774A0 (ru)
LT (1) LT3244889T (ru)
MD (1) MD3244889T2 (ru)
ME (1) ME03736B (ru)
MX (1) MX2017008879A (ru)
PL (1) PL3244889T3 (ru)
PT (1) PT3244889T (ru)
RS (1) RS60508B1 (ru)
SG (1) SG11201704964RA (ru)
SI (1) SI3244889T1 (ru)
UA (1) UA120864C2 (ru)
WO (1) WO2016113194A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018007288A1 (en) 2016-07-08 2018-01-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition comprising benzydamine
CN112514904B (zh) * 2021-01-26 2021-10-26 青岛农业大学 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224598D0 (en) 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
EP2018164B1 (de) 2006-05-12 2017-03-01 Christian Noe Verwendung von kombinationspräparaten, umfassend antimykotika
CN1887352A (zh) * 2006-07-13 2007-01-03 徐艳 治疗眼部真菌和细菌感染的组合物
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination

Also Published As

Publication number Publication date
CA2970060A1 (en) 2016-07-21
HUE049877T2 (hu) 2020-10-28
GEP20196962B (en) 2019-04-10
HRP20200815T1 (hr) 2020-08-07
ME03736B (me) 2021-01-20
EA035748B1 (ru) 2020-08-05
RS60508B1 (sr) 2020-08-31
WO2016113194A1 (en) 2016-07-21
KR102606081B1 (ko) 2023-11-24
IL252774A0 (en) 2017-08-31
AU2016208200B2 (en) 2020-09-03
SG11201704964RA (en) 2017-07-28
CN107106690A (zh) 2017-08-29
CN107106690B (zh) 2020-11-10
DK3244889T3 (da) 2020-06-02
KR20170101941A (ko) 2017-09-06
BR112017014295A2 (pt) 2018-03-06
UA120864C2 (uk) 2020-02-25
PL3244889T3 (pl) 2020-11-02
AR103381A1 (es) 2017-05-03
PT3244889T (pt) 2020-06-04
HK1246146A1 (zh) 2018-09-07
LT3244889T (lt) 2020-08-10
EP3244889A1 (en) 2017-11-22
US20180000783A1 (en) 2018-01-04
JP2018501277A (ja) 2018-01-18
US9962372B2 (en) 2018-05-08
JP6714597B2 (ja) 2020-06-24
MX2017008879A (es) 2018-03-28
MD3244889T2 (ro) 2020-06-30
EP3244889B1 (en) 2020-03-04
CA2970060C (en) 2023-10-03
CY1122979T1 (el) 2021-10-29
BR112017014295B1 (pt) 2023-04-25
AU2016208200A1 (en) 2017-06-29
SI3244889T1 (sl) 2020-08-31
ES2794824T3 (es) 2020-11-19

Similar Documents

Publication Publication Date Title
EA201890204A1 (ru) Антибактериальные соединения
MY187540A (en) Compounds active towards bromodomains
GB2541571A (en) Pharmaceutical compositions
EA202092456A3 (ru) Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
CL2015002897A1 (es) Inhibidores de bace1
EA201892822A1 (ru) Новые антибактериальные соединения
EA201991447A1 (ru) Снижение вязкости фармацевтических составов
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
EA201791174A1 (ru) Антимикотическое соединение
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
TR201901228T4 (tr) Vortioksetin piroglutamat.
EA201890364A1 (ru) СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t
EA201791716A1 (ru) Фармацевтический состав
CY1122979T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της μυκητιασης
BR112017004552A2 (pt) composições farmacêuticas
EA201990162A1 (ru) Фармацевтические композиции
EA202190626A3 (ru) Комбинация тразодона и габапентина для лечения боли
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
PH12016501448B1 (en) Antifungal composition
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.